(Q36368902)

English

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Marco Colleoni

12

0 references

4

object named as

Bent Ejlertsen

1 reference

Europe PubMed Central

13 August 2017

Aron Goldhirsch

16

object named as

Aron Goldhirsch

1 reference

Europe PubMed Central

13 August 2017

Manuela Rabaglio

10

object named as

Manuela Rabaglio

1 reference

Europe PubMed Central

13 August 2017

Beat Thürlimann

6

object named as

Beat Thürlimann

1 reference

Europe PubMed Central

13 August 2017

author name string

Marianne Ewertz

1

1 reference

Europe PubMed Central

13 August 2017

Kathryn P Gray

2

1 reference

Europe PubMed Central

13 August 2017

Meredith M Regan

3

1 reference

Europe PubMed Central

13 August 2017

Karen N Price

5

1 reference

Europe PubMed Central

13 August 2017

Hervé Bonnefoi

7

1 reference

Europe PubMed Central

13 August 2017

John F Forbes

8

1 reference

Europe PubMed Central

13 August 2017

Robert J Paridaens

9

1 reference

Europe PubMed Central

13 August 2017

Richard D Gelber

11

1 reference

Europe PubMed Central

13 August 2017

István Láng

13

1 reference

Europe PubMed Central

13 August 2017

Ian E Smith

14

1 reference

Europe PubMed Central

13 August 2017

Alan S Coates

15

1 reference

Europe PubMed Central

13 August 2017

Henning T Mouridsen

17

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

8 October 2012

1 reference

Europe PubMed Central

13 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

13 August 2017

30

1 reference

Europe PubMed Central

13 August 2017

32

1 reference

Europe PubMed Central

13 August 2017

3967-3975

1 reference

Europe PubMed Central

13 August 2017

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Obesity and breast cancer: status of leptin and adiponectin in pathological processes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Influence of obesity on breast cancer receptor status and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Minireview: Obesity and breast cancer: the estrogen connection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Adiposity and sex hormones in postmenopausal breast cancer survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Weight loss in breast cancer patient management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

30 September 2017

Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Obesity and breast cancer prognosis: weight of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Metabolic syndrome as a prognostic factor for breast cancer recurrences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Patterns of treatment effects in subsets of patients in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488270

21 September 2018

Effect of obesity on prognosis after early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23045588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23045588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23045588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23045588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://pubmed.ncbi.nlm.nih.gov/23045588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.40.8666

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36368902&oldid=1962660630"